Upgrade to SI Premium - Free Trial

LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c

March 19, 2025 4:51 PM

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($0.46).

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

Categories

Earnings